J. Michael French serves as Executive at SIRNA THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, J. Michael French has executed 11 insider transactions totaling $7.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 30, 2014 involved selling 309,055 shares valued at $102.0K.
J. Michael French currently holds 822,283 shares of SIRNA THERAPEUTICS INC (RNAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Michael French has been a net buyer of RNAI stock. They have purchased $7.5K and sold $0 worth of shares.
J. Michael French's most recent insider trade was on Dec 30, 2014, when they sold 309,055 shares at $0.33 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 31, 2011 | MRNA | $3.0K | Other | 5,000 | $0.60 | Discretionary |
| Sep 30, 2009 | MRNA | $4.2K | Other | 875 | $4.76 | Discretionary |
| Aug 11, 2008 | MRNA | $76 | Purchase | 100 | $0.76 | Discretionary |
| Aug 11, 2008 | MRNA | $755 | Purchase | 944 | $0.80 | Discretionary |
| Aug 11, 2008 | MRNA | $150 | Purchase | 200 | $0.75 | Discretionary |
| Aug 11, 2008 | MRNA | $1.3K | Purchase | 1,756 | $0.75 | Discretionary |
| Aug 11, 2008 | MRNA | $5.3K | Purchase | 7,000 | $0.75 | Discretionary |
| Dec 29, 2006 | RNAI | $0 | Disposition | 8,201 | $N/A | Discretionary |
| Feb 21, 2006 | RNAI | $0 | Award | 8,201 | $N/A | Discretionary |